Thus, depending on the cancer type FURIN inhibition is either beneficial (salivary gland tumors [2], skin cancer [3]) or disadvantageous (hepatocellular carcinoma [31]) or has no clear effect (CRC) on the tumorigenic process. The gene discussed is FURIN; the disease is hepatocellular carcinoma.